ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CBLL CeriBell Inc

20.03
0.94 (4.92%)
After Hours
Last Updated: 00:00:16
Delayed by 15 minutes
Share Name Share Symbol Market Type
CeriBell Inc NASDAQ:CBLL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.94 4.92% 20.03 18.24 22.14 20.85 19.20 19.62 277,394 00:00:16

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

29/10/2024 8:05pm

PR Newswire (US)


CeriBell (NASDAQ:CBLL)
Historical Stock Chart


From Oct 2024 to Jan 2025

Click Here for more CeriBell Charts.

SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ -- Ceribell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Ceribell (PRNewsfoto/Ceribell, Inc.)

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/. 

About Ceribell Inc.
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography ("EEG") platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in Sunnyvale, Calif.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com

Media Contact
Corrie Rose
Press@ceribell.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html

SOURCE Ceribell, Inc.

Copyright 2024 PR Newswire

1 Year CeriBell Chart

1 Year CeriBell Chart

1 Month CeriBell Chart

1 Month CeriBell Chart

Your Recent History

Delayed Upgrade Clock